» Articles » PMID: 34156979

Lupus Susceptibility Gene Esrrg Modulates Regulatory T Cells Through Mitochondrial Metabolism

Overview
Journal JCI Insight
Date 2021 Jun 22
PMID 34156979
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Estrogen-related receptor γ (Esrrg) is a murine lupus susceptibility gene associated with T cell activation. Here, we report that Esrrg controls Tregs through mitochondria homeostasis. Esrrg deficiency impaired the maintenance and function of Tregs, leading to global T cell activation and autoimmunity in aged mice. Further, Esrrg-deficient Tregs presented an impaired differentiation into follicular Tregs that enhanced follicular helper T cells' responses. Mechanistically, Esrrg-deficient Tregs presented with dysregulated mitochondria with decreased oxygen consumption as well as ATP and NAD+ production. In addition, Esrrg-deficient Tregs exhibited decreased phosphatidylinositol and TGF-β signaling pathways and increased mTOR complex 1 activation. We found that the expression of human ESRRG, which is high in Tregs, was lower in CD4+ T cells from patients with lupus than in healthy controls. Finally, knocking down ESRRG in Jurkat T cells decreased their metabolism. Together, our results reveal a critical role of Esrrg in the maintenance and metabolism of Tregs, which may provide a genetic link between lupus pathogenesis and mitochondrial dysfunction in T cells.

Citing Articles

Decrease of NAD Inhibits the Apoptosis of OLP T Cells via Inducing Mitochondrial Fission.

Zhang Z, Wang F, Zhou G J Inflamm Res. 2025; 18:1091-1106.

PMID: 39871961 PMC: 11771177. DOI: 10.2147/JIR.S502273.


Sensitivity of Mouse Lung Nuclear Receptors to Electronic Cigarette Aerosols and Influence of Sex Differences: A Pilot Study.

Sharma S, Rousselle D, Parker E, Ekpruke C, Alford R, Babayev M Int J Environ Res Public Health. 2024; 21(6).

PMID: 38929056 PMC: 11203813. DOI: 10.3390/ijerph21060810.


Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis.

Halfon M, Tankeu A, Ribi C Int J Mol Sci. 2024; 25(11).

PMID: 38892349 PMC: 11173067. DOI: 10.3390/ijms25116162.


Intersection of the microbiome and immune metabolism in lupus.

Garcia A, Six N, Ma L, Morel L Immunol Rev. 2024; 325(1):77-89.

PMID: 38873851 PMC: 11338729. DOI: 10.1111/imr.13360.


Lupus susceptibility gene controls the development, stability, and function of regulatory T cells via expression.

Choi S, Park Y, Roach T, Jimenez D, Fisher A, Zadeh M Sci Adv. 2024; 10(13):eadi4310.

PMID: 38536923 PMC: 10971436. DOI: 10.1126/sciadv.adi4310.


References
1.
Linterman M, Pierson W, Lee S, Kallies A, Kawamoto S, Rayner T . Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med. 2011; 17(8):975-82. PMC: 3182542. DOI: 10.1038/nm.2425. View

2.
Morel L, Tian X, Croker B, Wakeland E . Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity. 1999; 11(2):131-9. DOI: 10.1016/s1074-7613(00)80088-6. View

3.
Horwitz D . Identity of mysterious CD4+CD25-Foxp3+ cells in SLE. Arthritis Res Ther. 2010; 12(1):101. PMC: 2875622. DOI: 10.1186/ar2894. View

4.
Zhao C, Chu Y, Liang Z, Zhang B, Wang X, Jing X . Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients. BMC Immunol. 2019; 20(1):32. PMC: 6727508. DOI: 10.1186/s12865-019-0305-0. View

5.
von Spee-Mayer C, Siegert E, Abdirama D, Rose A, Klaus A, Alexander T . Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann Rheum Dis. 2015; 75(7):1407-15. DOI: 10.1136/annrheumdis-2015-207776. View